Clot Management Devices Market Size, Share, Industry, Forecast and Demand (2023-2030)

<h2>Global Clot Management Devices Market is Segmented By Product Type (Embolectomy Balloon Catheter, Catheter Directed Thrombolysis Devices, Percutaneous Thrombectomy Devices, Inferior Vena cava Filters, Neurovascular Embolectomy Devices, Others), By End-users (Hospitals, Ambulatory Surgical Centers, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, &nbsp;2023-2030.</h2>

<h3>Market Overview</h3>

<blockquote>
Global Clot Management Devices Market reached US$ YY&nbsp;billion in 2022 and is expected to reach US$ YY&nbsp;billion by 2030, growing with a CAGR of YY% during the forecast period 2023-2030.
</blockquote>

&nbsp;

Clot management devices are intended to prevent, identify, and treat problems linked to blood clots. Deep vein thrombosis (DVT), pulmonary embolism (PE), and arterial thrombosis are among the disorders that these devices are used to treat. Blood clots in blood arteries are mechanically removed using thrombectomy devices. These tools can be applied to the legs, lungs, and brain, among other body areas. Mechanical thrombectomy tools and aspiration catheters are two examples.

Catheter-Directed Catheters are used in thrombolysis devices to deliver thrombolytic drugs directly to the clot. These drugs aid in dissolving the clot and resuming blood flow. DVT, PE, and other diseases are frequently treated with catheter-directed thrombolysis. The prevalence of vascular diseases such as arterial thrombosis, pulmonary embolism, and deep vein thrombosis is on the rise, which has boosted the demand for clot management devices.

The development of more efficient and minimally invasive clot management tools has been made possible by ongoing developments in medical technology, improving patient outcomes and speeding up recovery.

<h3>Clot Management Devices Market Scope</h3>

<table cellspacing="0" style="border-collapse:collapse">
	<tbody>
		<tr>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #4472c4; border-right:none; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Metrics
			</td>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:none; border-right:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Details
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:none; border-top:none; width:312px">
			CAGR
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:none; border-right:1px solid #8eaadb; border-top:none; width:312px">
			YY%
			</td>
		</tr>
		<tr>
			<td style="border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:none; border-top:none; width:312px">
			Size Available for Years
			</td>
			<td style="border-bottom:1px solid #8eaadb; border-left:none; border-right:1px solid #8eaadb; border-top:none; width:312px">
			2021-2030
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:none; border-top:none; width:312px">
			Forecast Period
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:none; border-right:1px solid #8eaadb; border-top:none; width:312px">
			2023-2030
			</td>
		</tr>
		<tr>
			<td style="border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:none; border-top:none; width:312px">
			Data Availability
			</td>
			<td style="border-bottom:1px solid #8eaadb; border-left:none; border-right:1px solid #8eaadb; border-top:none; width:312px">
			Value (US$)
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:none; border-top:none; width:312px">
			Segments Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:none; border-right:1px solid #8eaadb; border-top:none; width:312px">
			Type, End-users
			</td>
		</tr>
		<tr>
			<td style="border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:none; border-top:none; width:312px">
			Regions Covered
			</td>
			<td style="border-bottom:1px solid #8eaadb; border-left:none; border-right:1px solid #8eaadb; border-top:none; width:312px">
			North America, Europe, Asia-Pacific, South America and Middle East &amp; Africa
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:none; border-top:none; width:312px">
			Fastest Growing Region
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:none; border-right:1px solid #8eaadb; border-top:none; width:312px">
			Asia-Pacific
			</td>
		</tr>
		<tr>
			<td style="border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:none; border-top:none; width:312px">
			Largest Region
			</td>
			<td style="border-bottom:1px solid #8eaadb; border-left:none; border-right:1px solid #8eaadb; border-top:none; width:312px">
			North America
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:none; border-top:none; width:312px">
			Report Insights Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:none; border-right:1px solid #8eaadb; border-top:none; width:312px">
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter&rsquo;s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.
			</td>
		</tr>
	</tbody>
</table>

&nbsp;

For more details on this report &ndash; <a href="https://www.datamintelligence.com/download-sample/clot-management-devices-market" target="_blank">Request for Sample</a>

&nbsp;

<h3>Clot Management Devices Market Dynamics</h3>

FDA Approvals

For instance, in January 2023,&nbsp;Penumbra, Inc., a worldwide healthcare firm focused on cutting-edge medicines reported that the most sophisticated and potent mechanical thrombectomy system on the market, Lightning Flash, has been approved for use by the U.S. Food and Drug Administration (FDA). Penumbra&#39;s innovative Lightning Intelligent Aspiration technology with twin clot detection algorithms, is featured in Lightning Flash. Lightning Flash is intended to quickly remove big blood clots from the body, such as venous thrombus and pulmonary emboli (PE), in conjunction with cutting-edge catheter engineering.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

The Penumbra ENGINE-powered Lightning Flash uses pressure- and flow-based algorithms to identify blood clots and blood flow. The MaxID hypotube technology used to create the Lightning Flash catheter allows for an inner diameter that is comparable to large-bore catheters while keeping a low profile and a soft, atraumatic tip intended to aid in navigating the intricate and delicate structure of the body. The device&#39;s combined use is meant to facilitate fast blood clot removal while limiting potential blood loss.

Active Major Players 

In March 2023, in some domestic Indian regions, SMT stated that it had been chosen as the sole distributor of Penumbra&#39;s peripheral and coronary vascular thrombectomy technology.&nbsp; In accordance with the terms of the contract, SMT will offer healthcare providers Penumbra&#39;s most recent Indigo System portfolio, including CATTM RX, which recently received approval from India&#39;s Central Drug Standard Control Organization, and Lightning technologies, upon regulatory approval, to treat conditions like coronary thrombosis, venous thrombosis, arterial thrombosis, and pulmonary embolism.&nbsp;

With Lightning Aspiration Tubing, Penumbra&#39;s Indigo System portfolio is the first and only computer-aided mechanical aspiration technology that can distinguish between clot and blood, reducing blood loss. It is designed for single-session blood clot removal in peripheral arterial and venous systems, including the treatment of pulmonary embolism. Additionally, Penumbra&#39;s Indigo System CAT RX is made to remove blood clots from the coronary and peripheral arteries safely and effectively.

Increasing Collaboration Among Key Players 

In June 2023, Sensome, a leader in the field of smart medical devices, and Asahi Intecc, a global leader in the guidewire industry, joined forces to create the next-generation Clotild Smart Guidewire. Asahi Intecc will be responsible for manufacturing this ground-breaking device for the treatment of acute ischemic stroke.

The most common cause of acquired long-term disability is a cerebral ischemic stroke, which is treatable with a treatment called mechanical thrombectomy. This procedure uses a thrombectomy tool that is guided along a wire from the wrist or groin to the blockage site to remove a clot that is clogging a blood artery in the brain. Rapid clot removal with little effort significantly improves patient outcomes.

Increasing Prevalence of Cardiovascular Diseases

According to the World Health Organization, with 17.9 million deaths per year, cardiovascular diseases (CVDs) are the leading cause of death worldwide. Coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other illnesses are among the categories of heart and blood vessel disorders known as CVDs. Heart attacks and strokes account for more than four out of every five CVD deaths, and one-third of these deaths happen before the age of 70.

According to a study that was published in the Journal of the American College of Cardiology, the estimated rates of cardiovascular risk factors and disease will considerably rise in the United States by the year 2060. Significant rises in cardiovascular trends could place a greater strain on the American healthcare system and underscore the need for fair access to early disease preventive services including education and treatment.

High Cost of Devices

In-depth engineering, research, and clinical testing are all necessary for the creation of new medical devices, and they all add to the overall price of bringing a product to market. Manufacturers must spend money on thorough testing and paperwork in order to comply with severe regulatory criteria for safety and efficacy, which raises the cost.

Specialized materials that adhere to strict requirements for sterility, durability, and biocompatibility are frequently needed for medical devices. The cost of obtaining and processing these resources can be high. Complex manufacturing procedures, trained personnel, and quality control procedures may be needed to produce intricate medical devices with cutting-edge technology.

Technical &nbsp;Challenges

Technical difficulties in ensuring that all components perform properly together can arise when creating medical devices with complex designs and functionalities. It can be difficult to ensure compatibility with current medical tools, practices, and workflows, particularly when incorporating new devices into mature infrastructures.

For devices to be used safely and effectively, user-friendly, intuitive interfaces for healthcare workers must be designed. Complex circulatory systems must be navigated with catheters while limiting injury to the surrounding tissues, which calls for expertise and high-tech imaging guidance.

<h3>Clot Management Devices Market Segment Analysis</h3>

The global clot management devices market is segmented based on type, end-user and region.

Catheter Directed Thrombolysis Devices Dominate the Market

Deep vein thrombosis (DVT) or pulmonary embolism are two conditions in which blood clots (thrombi) are clogging blood vessels in the legs. Catheter-directed thrombolysis (CDT) is a medical procedure used to treat both conditions. A small, flexible tube called a catheter is placed into the damaged blood artery. Typically, a small incision is used, and imaging methods like fluoroscopy or ultrasound are used to direct the catheter to the clot&#39;s location.

A thrombolytic agent, commonly referred to as a clot-dissolving medicine, is administered directly into the clot through the catheter. By dissolving the fibrin strands holding the clot together, thrombolytics enable the body&#39;s clot-dissolving systems to clear the impediment. Depending on the size and location of the clot, the length of time the drug is administered can change. The clot is intended to gradually dissolve, allowing blood flow to return. The remnants of the disintegrated clot may occasionally be naturally removed by blood flow. In other situations, the catheter could be utilized to manually or suctionally remove the clot fragments.

&nbsp;

<h3>Global Clot Management Devices Market Geographical Share</h3>

Advanced Healthcare Infrastructure, Increased Cardiovascular Disease

North America has been a dominant force in the global clot management devices market. Pulmonary embolism (PE) is a major cause of illness burden. PE is the third biggest cause of cardiovascular disease-related death in the United States, where it is expected to cause 100,000 fatalities annually.

There is growing evidence that prompt and thorough thrombus removal in deep vein thrombosis leads to better results, such as a lower incidence of post-thrombotic syndrome and incapacitating long-term symptoms. Catheter-directed thrombolysis works well to remove clots quickly, however, treatment comes with a high risk of bleeding. Without the need for systemic or catheter-directed thrombolytic therapy, percutaneous mechanical thrombectomy is a very efficient way to remove clots.

For instance, Edwards Lifesciences Corporation offers the Fogarty graft thrombectomy catheter. AV fistulas for dialysis access and grafts for iliofemoral bypass are two examples of synthetic bypass grafts that are intended to be cleaned of organized thrombus and adhering thrombotic debris. They provide a wider range of diameters than the Fogarty adherent clot catheter, which is useful for a thrombus that is too resistant for an elastomeric balloon.

<h3>COVID-19 Impact Analysis</h3>

The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global clot management devices market. Many healthcare systems reallocated resources to deal with COVID-19 cases at the height of the pandemic. Non-urgent medical operations, such as those involving clot management, were consequently delayed.

The management of COVID-19 patients took over hospitals&#39; and healthcare facilities&#39; attention, which had an impact on the resources available for treating other medical disorders. Patient visits to healthcare facilities for conditions unrelated to COVID-19 decreased because of lockdowns, limits on movement, and patient fears of getting the virus.

<h3>Russia-Ukraine War Impact&nbsp;</h3>

Healthcare systems may be under pressure by armed situations that take resources and focus away from treatments involving clot management devices. The violence may interrupt supply lines for medical equipment and supplies, which could influence the accessibility of clot control devices.

Patients&#39; ability to reach medical facilities and receive timely clot management therapies is hampered by the conflict. Elective procedures like clot management interventions are delayed if healthcare facilities prioritize urgent cases over non-urgent ones.

<h3>Key Developments</h3>

<ul>
	<li>In August 2022, Inari Medical announced a trial for the ClotTriever system to treat iliofemoral deep vein thrombosis (DVT).</li>
</ul>

<h3>Competitive Landscape</h3>

The major global players in the market include Medtronic Plc, Boston Scientific Corporation, Edward Lifesciences, Teleflex Incorporated, Johnson &amp; Johnson, LeMaitre Vascular, Inc., AngioDynamics, iVascular SLU, Cardinal Health, and Stryker.

<h3>Why Purchase the Report?</h3>

<ul>
	<li>To visualize the global clot management devices market segmentation based on product, end-users, and region as well as understand key commercial assets and players.</li>
	<li>Identify commercial opportunities by analyzing trends and co-development.</li>
	<li>Excel data sheet with numerous data points of clot management devices market-level with all segments.</li>
	<li>PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.</li>
	<li>Product mapping available as excel consisting of key products of all the major players.</li>
</ul>

The global clot management devices market report would provide approximately 61 tables, 58 figures, and 186 Pages.

<h3>Target Audience 2023</h3>

<ul>
	<li>Manufacturers/ Buyers</li>
	<li>Industry Investors/Investment Bankers</li>
	<li>Research Professionals</li>
	<li>Emerging Companies</li>
</ul>

<ol>
	<li>Methodology and Scope
	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>Definition and Overview</li>
	<li>Executive Summary
	<ol>
		<li>Snippet by Product</li>
		<li>Snippet by End-users</li>
		<li>Snippet by Region</li>
	</ol>
	</li>
	<li>Dynamics
	<ol>
		<li>Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>FDA Approval</li>
				<li>Active Major Players</li>
				<li>Increasing Collaboration Among Key Players</li>
				<li>Increasing Prevalence of Cardiovascular Diseases</li>
			</ol>
			</li>
			<li>Restraints
			<ol>
				<li>High Cost of Devices</li>
				<li>Technical Challenges</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>Industry Analysis
	<ol>
		<li>Porter&#39;s Five Force Analysis</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Russia-Ukraine War Impact Analysis</li>
		<li>DMI Opinion</li>
	</ol>
	</li>
	<li>COVID-19 Analysis
	<ol>
		<li>Analysis of COVID-19
		<ol>
			<li>Scenario Before COVID</li>
			<li>Scenario During COVID</li>
			<li>Scenario Post COVID</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid COVID-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion</li>
	</ol>
	</li>
	<li>By Product
	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Attractiveness Index, By Product</li>
		</ol>
		</li>
		<li>Embolectomy Balloon Catheter*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Catheter Directed Thrombolysis Devices</li>
		<li>Percutaneous Thrombectomy Devices</li>
		<li>Inferior Vena cava Filters</li>
		<li>Neurovascular Embolectomy Devices</li>
		<li>Others</li>
	</ol>
	</li>
	<li>By End-user
	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user</li>
			<li>Market Attractiveness Index, By End-user</li>
		</ol>
		</li>
		<li>Commercial and Infrastructure*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Residential</li>
		<li>Industrial</li>
	</ol>
	</li>
	<li>By Region
	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>UK</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia-Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia-Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>Competitive Landscape
	<ol>
		<li>Competitive Scenario</li>
		<li>Market Positioning/Share Analysis</li>
		<li>Mergers and Acquisitions Analysis</li>
	</ol>
	</li>
	<li>Company Profiles
	<ol>
		<li>Medtronic Plc*
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Financial Overview</li>
			<li>Key Developments</li>
		</ol>
		</li>
		<li>Boston Scientific Corporation</li>
		<li>Edward Lifesciences</li>
		<li>Teleflex Incorporated</li>
		<li>Johnson &amp; Johnson</li>
		<li>LeMaitre Vascular, Inc.</li>
		<li>AngioDynamics</li>
		<li>iVascular SLU</li>
		<li>Cardinal Health</li>
		<li>Stryker (*LIST NOT EXHAUSTIVE)</li>
	</ol>
	</li>
	<li>Appendix
	<ol>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

&nbsp;

<ul>
</ul>

Table 1 Global Clot Management Devices Market Value, By Product, 2022, 2026 &amp; 2030 (US$ Million)

Table 2 Global Clot Management Devices Market Value, By End-user, 2022, 2026 &amp; 2030 (US$ Million)

Table 3 Global Clot Management Devices Market Value, By Region, 2022, 2026 &amp; 2030 (US$ Million)

Table 4 Global Clot Management Devices Market Value, By Product, 2022, 2026 &amp; 2030 (US$ Million)

Table 5 Global Clot Management Devices Market Value, By Product, 2021-2030 (US$ Million)

Table 6 Global Clot Management Devices Market Value, By End-user, 2022, 2026 &amp; 2030 (US$ Million)

Table 7 Global Clot Management Devices Market Value, By End-user, 2021-2030 (US$ Million)

Table 8 Global Clot Management Devices Market Value, By Region, 2022, 2026 &amp; 2030 (US$ Million)

Table 9 Global Clot Management Devices Market Value, By Region, 2021-2030 (US$ Million)

Table 10 North America Clot Management Devices Market Value, By Product, 2021-2030 (US$ Million)

Table 11 North America Clot Management Devices Market Value, By End-user, 2021-2030 (US$ Million)

Table 12 North America Clot Management Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 13 South America Clot Management Devices Market Value, By Product, 2021-2030 (US$ Million)

Table 14 South America Clot Management Devices Market Value, By End-user, 2021-2030 (US$ Million)

Table 15 South America Clot Management Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 16 Europe Clot Management Devices Market Value, By Product, 2021-2030 (US$ Million)

Table 17 Europe Clot Management Devices Market Value, By End-user, 2021-2030 (US$ Million)

Table 18 Europe Clot Management Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 19 Asia-Pacific Clot Management Devices Market Value, By Product, 2021-2030 (US$ Million)

Table 20 Asia-Pacific Clot Management Devices Market Value, By End-user, 2021-2030 (US$ Million)

Table 21 Asia-Pacific Clot Management Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 22 Middle East &amp; Africa Clot Management Devices Market Value, By Product, 2021-2030 (US$ Million)

Table 23 Middle East &amp; Africa Clot Management Devices Market Value, By End-user, 2021-2030 (US$ Million)

Table 24 Medtronic Plc: Overview

Table 25 Medtronic Plc: Product Portfolio

Table 26 Medtronic Plc: Key Developments

Table 27 Boston Scientific Corporation: Overview

Table 28 Boston Scientific Corporation: Product Portfolio

Table 29 Boston Scientific Corporation: Key Developments

Table 30 Edward Lifesciences: Overview

Table 31 Edward Lifesciences: Product Portfolio

Table 32 Edward Lifesciences: Key Developments

Table 33 Teleflex Incorporated: Overview

Table 34 Teleflex Incorporated: Product Portfolio

Table 35 Teleflex Incorporated: Key Developments

Table 36 Johnson &amp; Johnson: Overview

Table 37 Johnson &amp; Johnson: Product Portfolio

Table 38 Johnson &amp; Johnson: Key Developments

Table 39 LeMaitre Vascular, Inc.: Overview

Table 40 LeMaitre Vascular, Inc.: Product Portfolio

Table 41 LeMaitre Vascular, Inc.: Key Developments

Table 42 AngioDynamics: Overview

Table 43 AngioDynamics: Product Portfolio

Table 44 AngioDynamics: Key Developments

Table 45 iVascular SLU: Overview

Table 46 iVascular SLU: Product Portfolio

Table 47 iVascular SLU: Key Developments

Table 48 Cardinal Health: Overview

Table 49 Cardinal Health: Product Portfolio

Table 50 Cardinal Health: Key Developments

Table 51 Stryker: Overview

Table 52 Stryker: Product Portfolio

Table 53 Stryker: Key Developments

List of Figures

Figure 1 Global Clot Management Devices Market Value, 2021-2030 (US$ Million)

Figure 2 Global Clot Management Devices Market Share, By Product, 2022 &amp; 2030 (%)

Figure 3 Global Clot Management Devices Market Share, By End-user, 2022 &amp; 2030 (%)

Figure 4 Global Clot Management Devices Market Share, By Region, 2022 &amp; 2030 (%)

Figure 5 Global Clot Management Devices Market Y-o-Y Growth, By Product, 2022-2030 (%)

Figure 6 Embolectomy Balloon Catheter Clot Management Devices Market Value, 2021-2030 (US$ Million)

Figure 7 Catheter Directed Thrombolysis Devices Clot Management Devices Market Value, 2021-2030 (US$ Million)

Figure 8 Percutaneous Thrombectomy Devices Clot Management Devices Market Value, 2021-2030 (US$ Million)

Figure 9 Inferior Vena cava Filters Clot Management Devices Market Value, 2021-2030 (US$ Million)

Figure 10 Neurovascular Embolectomy Devices Clot Management Devices Market Value, 2021-2030 (US$ Million)

Figure 11 Others Clot Management Devices Market Value, 2021-2030 (US$ Million)

Figure 12 Global Clot Management Devices Market Y-o-Y Growth, By End-user, 2022-2030 (%)

Figure 13 Hospitals End-user in Global Clot Management Devices Market Value, 2021-2030 (US$ Million)

Figure 14 Ambulatory Surgical Centers End-user in Global Clot Management Devices Market Value, 2021-2030 (US$ Million)

Figure 15 Others End-user in Global Clot Management Devices Market Value, 2021-2030 (US$ Million)

Figure 16 Global Clot Management Devices Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 17 North America Clot Management Devices Market Value, 2021-2030 (US$ Million)

Figure 18 Asia-Pacific Clot Management Devices Market Value, 2021-2030 (US$ Million)

Figure 19 Europe Clot Management Devices Market Value, 2021-2030 (US$ Million)

Figure 20 South America Clot Management Devices Market Value, 2021-2030 (US$ Million)

Figure 21 Middle East and Africa Clot Management Devices Market Value, 2021-2030 (US$ Million)

Figure 22 North America Clot Management Devices Market Value, 2021-2030 (US$ Million)

Figure 23 North America Clot Management Devices Market Share, By Product, 2022 &amp; 2030 (%)

Figure 24 North America Clot Management Devices Market Share, By End-user, 2022 &amp; 2030 (%)

Figure 25 North America Clot Management Devices Market Share, By Country, 2022 &amp; 2030 (%)

Figure 26 South America Clot Management Devices Market Value, 2021-2030 (US$ Million)

Figure 27 South America Clot Management Devices Market Share, By Product, 2022 &amp; 2030 (%)

Figure 28 South America Clot Management Devices Market Share, By End-user, 2022 &amp; 2030 (%)

Figure 29 South America Clot Management Devices Market Share, By Country, 2022 &amp; 2030 (%)

Figure 30 Europe Clot Management Devices Market Value, 2021-2030 (US$ Million)

Figure 31 Europe Clot Management Devices Market Share, By Product, 2022 &amp; 2030 (%)

Figure 32 Europe Clot Management Devices Market Share, By End-user, 2022 &amp; 2030 (%)

Figure 33 Europe Clot Management Devices Market Share, By Country, 2022 &amp; 2030 (%)

Figure 34 Asia-Pacific Clot Management Devices Market Value, 2021-2030 (US$ Million)

Figure 35 Asia-Pacific Clot Management Devices Market Share, By Product, 2022 &amp; 2030 (%)

Figure 36 Asia-Pacific Clot Management Devices Market Share, By End-user, 2022 &amp; 2030 (%)

Figure 37 Asia-Pacific Clot Management Devices Market Share, By Country, 2022 &amp; 2030 (%)

Figure 38 Middle East &amp; Africa Clot Management Devices Market Value, 2021-2030 (US$ Million)

Figure 39 Middle East &amp; Africa Clot Management Devices Market Share, By Product, 2022 &amp; 2030 (%)

Figure 40 Middle East &amp; Africa Clot Management Devices Market Share, By End-user, 2022 &amp; 2030 (%)

Figure 41 Medtronic Plc: Financials

Figure 42 Boston Scientific Corporation: Financials

Figure 43 Edward Lifesciences: Financials

Figure 44 Teleflex Incorporated: Financials

Figure 45 Johnson &amp; Johnson: Financials

Figure 46 LeMaitre Vascular, Inc.: Financials

Figure 47 AngioDynamics: Financials

Figure 48 iVascular SLU: Financials

Figure 49 Cardinal Health: Financials

Figure 50 Stryker: Financials

Clot Management Devices Market Size, Share, Industry, Forecast and Demand (2023-2030)

Blood Clotting Factors Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2024 February 07

Starting from

Blood Platelets Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2024 February 20

Starting from

Blood Collection Devices Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2024 February 07

Starting from